CME Group (CME)
(Delayed Data from NSDQ)
$222.04 USD
+0.87 (0.39%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $222.04 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$222.04 USD
+0.87 (0.39%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $222.04 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
Zacks News
CME (CME) Up 1.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
CME (CME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Holding CME Group (CME) Stock is a Prudent Move
by Zacks Equity Research
A compelling product portfolio, global presence, focus on over-the-counter clearing services and effective capital deployment poise CME Group (CME) for growth.
Zacks Industry Outlook Highlights Intercontinental Exchange, CME Group, Cboe, Global Markets, Nasdaq and MarketAxess Holdings
by Zacks Equity Research
Intercontinental Exchange, CME Group, Cboe, Global Markets, Nasdaq and MarketAxess Holdings are part of the Zacks Industry Outlook article.
5 Securities and Exchanges Stocks to Gain From Increased Trading
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, CBOE, NDAQ and MKTX. However, compliance with regulations remains a challenge.
Here's Why Hold is an Apt Strategy for CME Group (CME) Stock
by Zacks Equity Research
A compelling product portfolio, global presence, focus on over-the-counter clearing services and effective capital deployment poise CME Group (CME) for growth.
The Zacks Analyst Blog Highlights Meta Platforms, Becton Dickinson, CME Group, Chipotle Mexican Grill and ParkerHannifin
by Zacks Equity Research
Meta Platforms, Becton Dickinson, CME Group, Chipotle Mexican Grill and ParkerHannifin are included in this Analyst Blog.
Top Analyst Reports for Meta Platforms, Becton Dickinson & CME Group
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Meta Platforms, Inc. (META), Becton, Dickinson and Company (BDX) and CME Group (CME).
Cboe Global (CBOE) Q3 Earnings, Revenues Top, View Revised
by Zacks Equity Research
Cboe Global (CBOE) Q3 results reflect record net revenues and adjusted earnings, courtesy of a robust derivatives franchise, supported by sizable contributions from data and access solutions and cash and spot markets.
Intercontinental (ICE) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Intercontinental (ICE) Q3 results reflect persistent revenue growth, driven by strong Exchanges and Fixed Income and Data Services. The results benefited from the strength of its technology and data services.
CME Group (CME) Q3 Earnings Beat on Higher Trading Volume
by Zacks Equity Research
CME Group (CME) Q3 results reflect higher revenues, driven by increased trading volume.
CME Group (CME) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 2.59% and 0.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
CME Group (CME) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
CME Group's (CME) Q3 earnings are likely to have been aided by improved clearing, transaction fees and other revenues, and market data and information services. However, higher expenses might have been an offset.
Nasdaq (NDAQ) Beats on Q3 Earnings, Cuts Expense View
by Zacks Equity Research
Nasdaq (NDAQ) Q3 earnings reflect solid performance in both segments.
CME Group (CME) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CME (CME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nasdaq (NDAQ) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Solid organic revenue growth, strong performance at index and analytics businesses and contributions from the acquisition of Verafin are likely to have aided Nasdaq's third-quarter performance.
MarketAxess (MKTX) Gears Up for Q3 Earnings: What to Expect?
by Zacks Equity Research
MarketAxess' (MKTX) third-quarter results are likely to gain from increased total commissions.
Here's How Investors Can Find Strong Finance Stocks with the Zacks ESP Screener
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Top Stock Reports for PepsiCo, Thermo Fisher Scientific & Canadian National Railway
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including PepsiCo, Inc. (PEP), Thermo Fisher Scientific Inc. (TMO) and Canadian National Railway Company (CNI).
The Zacks Analyst Blog Highlights Merck, Cisco, Morgan Stanley, CME Group and Canadian Natural Resources
by Zacks Equity Research
Merck, Cisco, Morgan Stanley, CME Group and Canadian Natural Resources are included in this Analyst Blog.
Top Analyst Reports for Merck, Cisco & Morgan Stanley
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Cisco Systems, Inc. (CSCO) and Morgan Stanley (MS).
CME Group (CME) to Introduce E-mini Nasdaq-100 Weekly Options
by Zacks Equity Research
CME Group (CME) is set to launch Weekly options on Oct 3 to add to the robust suite of Monday, Wednesday and Friday Weeklies, End-of-Month and Quarterly options.
Zacks Industry Outlook Highlights Intercontinental Exchange, CME Group, Cboe Global Markets, Nasdaq and MarketAxess
by Zacks Equity Research
Intercontinental Exchange, CME Group, Cboe Global Markets, Nasdaq and MarketAxess have been highlighted in this Industry Outlook article.
5 Securities and Exchanges to Gain From Increased Volatility
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, CBOE, NDAQ and MKTX. However, compliance with regulations remains a challenge.
Why Should You Stay Invested in CME Group (CME) Stock Now?
by Zacks Equity Research
Increased volatility driving improved volumes should fuel clearing and transaction fees, improving non-transactional revenues and adequate financial flexibility bodes well for CME Group (CME).
Coinbase Global (COIN) Q2 Earnings Miss on Lower Trading Volume
by Zacks Equity Research
Coinbase (COIN) Q2 results reflect lower trading volumes in both retail and institutional as the trend of both lower crypto asset prices and volatility that began in late 2021 continued into the second quarter of 2022.